OR WAIT null SECS
August 01, 2014
Developments in chromatography column technology to deliver greater efficiency, speed and inertness benefit the drug development process from discovery to manufacturing and quality control.
Contract research, development, and manufacturing organizations invested in new facilities and technologies in 2014 for analytical testing, as well as small- and large-molecule drug development.
Experts from contract testing laboratories and service organizations shared their perceptions of analytical testing advances, and challenges still ahead.
May 02, 2014
Industry experts discuss how extractables and leachables studies are designed using a risk-based approach.
Data integrity in the analytical laboratory is an area of increasing focus for regulators such as FDA.
February 01, 2014
For a drug-development process that relies on outsourced services, special considerations are needed to ensure the proper transfer of technology and information from one phase to the next.
July 02, 2013
Understanding the supply-chain challenge and coupling high-efficiency chromatographic techniques with information-rich detectors are leading to improvements in the management of extractables and leachables in parenteral drugs.
August 02, 2011
Thomas P. Layloff describes the advantages of using thin-layer chromatography methods for counterfeit detection. This article contains bonus online material.
November 21, 2007
Company and People Notes: Cambridge Major Labs acquires ChemShop; Helix BioPharma restructures senior positions, more.